ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Pakistan: Hospitals begin clinical trials of plasma therapy as first Covid-19 patient fully recovers

Karachi [Pakistan], May 11 (ANI): Pakistan's top hematologist said that three hospitals in the country have started clinical trials for passive immunisation with the support of National Institute of Blood Disease (NIBD) to treat the Covid-19 patients

ANI May 11, 2020 14:56 IST googleads

Representative image

Karachi [Pakistan], May 11 (ANI): Pakistan's top hematologist said that three hospitals in the country have started clinical trials for passive immunisation with the support of National Institute of Blood Disease (NIBD) to treat the Covid-19 patients.
The NIBD head, Dr Tahir Shamsi, told The Express Tribune on Sunday that five more hospitals across the country have also sought the Drug Regulatory of Pakistan (Drap) nod to conduct the clinical trials for passive immunisation.
Last month, Drap had granted approval for a passive immunisation under which the blood plasma is infused to coronavirus patients to help their immune system to fight off the highly-contagious disease.
Convalescent plasma taken from a recovered Covid-19 patient is believed to be rich in the antibodies needed to cure the deadly infection.
The technique is used when there is a high risk of infection and insufficient time for the body to develop its own immune response or to reduce the symptoms of ongoing or immunosuppressive diseases.
Pakistani doctors on Saturday claimed a successful clinical trial of passive immuinization after a coronavirus patient recovered through plasma therapy.
Shamsi said that the country's first Covid-19 patient was fully recovered from the mysterious illness within seven days and tested negative for the novel coronavirus after he was treated through plasma therapy.
The NIBD chief also said more than one dozen Covid-19 patients in Karachi are being treated through plasma therapy and three medical facilities in other parts of the country are also allowed to use the similar technique, which is also approved registered by the US Food and Drug Administration (FDA) and World Health Organisation (WHO) to treat Covid-19 patients.
Shamsi was the first medical expert in the country who had proposed the technique to the government authorities for the treatment of Covid-19 following the pandemic outbreak.
According to the NIBD research team, no evidence of reinfection found in the recovered coronavirus patients after they donated their blood.
Shamsi also warned that the number of Covid-19 cases could cross 80,000 mark and the medical facilities in the country could get overwhelmed by the end of May.
Currently, the nationwide tally of Covid-19 patients stands at 30,941. The virus has claimed at least 667 lives while at least 8,212 coronavirus patients have recovered. (ANI)

Get the App

What to Read Next

Asia

India consistently supported Maldives in crisis: Mohamed Nasheed

India consistently supported Maldives in crisis: Mohamed Nasheed

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Read More
Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Europe

Akshar Foundation highlights Northeast India’s development at UN

Akshar Foundation highlights Northeast India’s development at UN

On the sidelines of the 61st session of the United Nations Human Rights Council (UNHRC), Mazin Mukhtar, Co-founder and Associate Director of the Akshar Foundation, highlighted development initiatives in India's northeastern region and urged global recognition of progress made in previously neglected areas.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.